Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy
Clinical trial NCT03463161 · TERMINATED
Trial details
- NCT number
- NCT03463161
- Sponsor
- University of Chicago
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-23
- Primary completion
- 2018-12-04
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.